Dopamine D2 Receptor Antagonists
"Dopamine D2 Receptor Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds and drugs that bind to and inhibit or block the activation of DOPAMINE D2 RECEPTORS.
| Descriptor ID |
D065127
|
| MeSH Number(s) |
D27.505.519.625.150.175.500 D27.505.696.577.150.175.500
|
| Concept/Terms |
Dopamine D2 Receptor Antagonists- Dopamine D2 Receptor Antagonists
- Receptor Antagonists, Dopamine D2
- Dopamine D2 Antagonists
- Antagonists, Dopamine D2
- D2 Antagonists, Dopamine
|
Below are MeSH descriptors whose meaning is more general than "Dopamine D2 Receptor Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Dopamine D2 Receptor Antagonists".
This graph shows the total number of publications written about "Dopamine D2 Receptor Antagonists" by people in this website by year, and whether "Dopamine D2 Receptor Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dopamine D2 Receptor Antagonists" by people in Profiles.
-
Oberweis B, Gragnoli C. Potential role of prolactin in antipsychotic-mediated association of schizophrenia and type 2 diabetes. J Cell Physiol. 2012 Aug; 227(8):3001-6.
-
Collins LE, Sager TN, Sams AG, Pennarola A, Port RG, Shahriari M, Salamone JD. The novel adenosine A2A antagonist Lu AA47070 reverses the motor and motivational effects produced by dopamine D2 receptor blockade. Pharmacol Biochem Behav. 2012 Jan; 100(3):498-505.
-
Dusitanond P, Young WB. Neuroleptics and migraine. Cent Nerv Syst Agents Med Chem. 2009 Mar; 9(1):63-70.
-
Claudi F, Di Stefano A, Napolitani F, Cingolani GM, Giorgioni G, Fontenla JA, Montenegro GY, Rivas ME, Rosa E, Michelotto B, Orlando G, Brunetti L. Binding and preliminary evaluation of 5-hydroxy- and 10-hydroxy-2,3, 12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinolines as dopamine receptor ligands. J Med Chem. 2000 Feb 24; 43(4):599-608.
-
Lidsky TI, Yablonsky-Alter E, Zuck LG, Banerjee SP. Antipsychotic drug effects on glutamatergic activity. Brain Res. 1997 Aug 01; 764(1-2):46-52.
-
Lidsky TI, Banerjee SP. Acute administration of haloperidol enhances dopaminergic transmission. J Pharmacol Exp Ther. 1993 Jun; 265(3):1193-8.